Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu, China.
Correspondence Address: Dr. Ji-Jun Shi, Department of Neurology, The Second Affiliated Hospital of Soochow University, No. 1055, Sanxiang Road, Suzhou 215004, Jiangsu, China. E-mail: firstname.lastname@example.org
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which allows others to remix, tweak and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Fibromuscular dysplasia (FMD) is a non-inflammatory, non-atherosclerotic, and multifocal vascular disease, commonly involving the cerebral and renal arteries. Cerebrovascular stenosis and spontaneous dissection resulting from cerebrovascular FMD (cFMD) is one of the important causes of young stroke. Here we reported the case of cFMD in a 28-year-old male patient with stroke. Digital subtraction angiogram demonstrated dissecting aneurysm in the carotid artery and multiple stenoses in both vertebral arteries. Endovascular angioplasty with balloon predilation and stenting was successfully performed for the patient, when medical treatment is not adequate. The follow-up showed remarkable improvement and no recurrence of stroke.
Angioplasty, fibromuscular dysplasia, stent, therapy, young stroke
Fibromuscular dysplasia (FMD) is an uncommon vascular disease that occurs more often in young women. FMD mainly involves the renal and cerebral arteries. Cerebrovascular FMD (cFMD) can be complicated by stroke and associated with headaches, and it can also be associated with intracranial aneurysms with a high risk of subarachnoid hemorrhage. The cerebrovascular stenosis and dissection, as a result of FMD, is one of the important causes of stroke in the young (15-45 years old). A case report of cFMD treated with angioplasty and stenting in a young male patient is presented, along with an overview of the available literature.
A 28-year-old male patient was admitted to our stroke unit ward of department of neurology in the Second Affiliated Hospital of Soochow University because of ischemic stroke with inarticulate speech and paralysis of right limbs. The patient had no medical history of traditional cerebrovascular risk factors, such as hypertension. The patient also had no personal or family history of stroke. The dysphasia and slight right-sided weakness occurred without definite causes one day before admission without any prior warning. Magnetic resonance imaging revealed a new infarction lesion on the left temporal lobe and occlusion of the left internal carotid artery (ICA). The ultrasound sonography also demonstrated occlusion in the left ICA. Antiplatelet (clopidogrel 75 mg and aspirin 100 mg q.d. p.o.) and statin therapy (atorvastatin 40mg q.n. p.o.) were given to this patient diagnosed as acute cerebral infarction without a clear etiology. During this hospitalization for seven days, logaphasia and more severe paralysis of the right limbs occurred. Then, he was transferred to our stroke unit ward for further vascular evaluation and interventional therapy. The positive neurological signs were as follows: incomplete logaphasia, central facial paralysis, right-sided hemiparesis (4/5) and positive Babinski sign. Other laboratory tests about thyroid function, autoimmune antibodies and vasculitis indicators were all normal.
Digital subtraction angiography (DSA) showed a dissecting aneurysm of the C1 segment of right ICA and subtotal occlusion of the left ICA [Figure 1a and b]. Anterior communicating artery was open, and the left middle cerebral artery (MCA) territory got collateral blood flow from the right MCA [Figure 1c]. Severe bilateral stenosis (> 70%) was also revealed on the V2 segment of both vertebral arteries (VA) [Figure 1d-f]. Then angioplasty and stenting was performed for this young patient.
Figure 1. (a) The dissecting aneurysm on the C1 segment of right internal carotid artery; (b) "rat tail sign" of the left internal carotid artery before predilation; (c) the anterior communicating artery was open and the left middle cerebral artery territory got collateral blood flow from the right middle cerebral artery; (d‑f) severe bilateral stenosis on the V2 segment of both VAs; (g) left vertebral arteries after stenting; (h) left internal carotid artery after balloon predilation
First, the vertebral angioplasty and stenting was performed and then the left ICA was stented because of the carotid sinus reaction. A dissecting stenosis on the initial segment of the left VA stenosis was found during the angiography before stenting. Firstly, one expanding stent was placed on the dissecting site and then another two stents (4 mm × 60 mm and 4 mm × 40 mm) were delivered and deployed to cover the long stenotic lesion. A final angiography demonstrated excellent stent placement across the stenotic lesion of the left VA and left vertebral angiogram revealed good flow in vertebral and basilar arteries [Figure 1g].
After advancing the 8F guiding catheter within the C1 segment of the left ICA, a microwire (0.014 inches) was delivered through the subtotal occlusive site and predilation was performed with a balloon (2.5 mm × 15 mm) at 6 atm. Then the stent (4 mm × 40mm Xpert Stent System) was deployed over the stenosis and post-dilation was performed with a balloon at 6 atm. Angiography after stenting showed revascularization of the subtotal stenosis and good flow across the stent with complete disappearance of this stenosis [Figure 1h]. After the procedure, antiplatelet therapy (clopidogrel 75 mg and aspirin 100 mg daily) was sequentially administered for 3 months, and then aspirin is taken prophylactically. During the follow-up period of three years, this patient was normal at three months after discharged from our hospital, and no recurrent stroke occurred.
FMD is a non-inflammatory, non-atherosclerotic vascular disease that commonly involves the renal and internal carotid arteries. The young patient has multiple vascular stenoses, but no cerebrovascular risk factors, therefore cFMD can be diagnosed. The prevalence of symptomatic renal artery FMD is about four in 1000 and the prevalence of cFMD is probably half that.[1-4] FMD usually affects females from 15 to 50 years of age and accounts for around 10% of cases of renal artery stenosis.[1-4]
Although the etiology of FMD is not well understood, several mechanisms have been proposed. For example, genetic predisposition, hormonal factors and arterial wall ischemia.[1,4] The pathogenesis of FMD remains unclear. A number of theories have been proposed, including environmental factors, such as smoking and estrogen, as well as genetic factors; however, about 10% of patients with FMD have an affected family member.
cFMD may be asymptomatic or associated with a variety of nonspecific symptoms, including headache, tinnitus, vertigo, lightheadedness and syncope. The clinical manifestations of cFMD are variable and depend on a number of factors, including the distribution of vascular bed involvement and the type and severity of the vascular lesions.[6,7] The more specific neurologic syndromes of TIA, amaurosis fugax, stroke, Horner’s syndrome, and cranial-nerve palsies may be the first presentation of FMD involving the carotid or VA. And the most feared and serious sequelae of cFMD include TIA, stroke, subarachnoid hemorrhage and cervical artery dissection. It shows that FMD is present in about 15%-20% of patients with a spontaneous dissection of carotid or VA. And multiple cervical artery dissections are more common in patients with an underlying arteriopathy, such as FMD.
Non-invasive imaging modalities for diagnosing FMD include Doppler ultrasound, computed tomographic angiography and magnetic resonance angiography. The accepted gold standard for the diagnosis of cFMD is DSA. "String of beads pattern" in the pathological carotid or renal arteries is an important and most common angiographic finding and is present in over 90% of cases. However, it was not observed in this present case. This invasive test should be considered for those symptomatic patients in whom intervention is contemplated or for cases in which there is uncertainty about the patient’s diagnosis or severity of disease.
Medical therapy and revascularization are the two major treatment options for cFMD patients. As previously discussed, antiplatelet therapy is the mainstay of the medical therapy. For symptomatic patients with carotid or vertebral artery FMD who have suffered a dissection, angioplasty with stenting may be performed. The indications for intervening in cFMD are for those in whom antiplatelet or anticoagulant therapy is contraindicated or less effective and for those cFMD patients with pseudoaneurysm formation, usually the result of a prior dissection.
The patient was successfully treated with angioplasty with stenting. During the follow-up period, no adverse events and complications were observed suggesting that angioplasty with stenting may be a safe and effective treatment method for this condition.
This study was supported by the National Natural Science Foundation of China (Grant No. 81471195) and the second affiliated hospital of Soochow university preponderant clinic discipline group project funding (Grant No. XKQ2015002).
There are no conflicts of interest.
1. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004;350:1862-71.DOIPubMed
2. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis 2007;2:28.DOIPubMedPMC
3. Shejul YK, Viswanathan MK, Jangale P, Kulkarni A. Fibromuscular dysplasia: a cause of secondary hypertension. Korean J Intern Med 2014;29:840-1.DOIPubMedPMC
4. Mettinger KL. Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke 1982;13:53-8.DOI
5. Poloskey SL, Olin JW, Mace P, Gornik HL. Fibromuscular dysplasia. Circulation 2012;125:e636-9.
6. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, McBane RD, Kline-Rogers E, White CJ, Gornik HL. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012;125:3182-90.DOIPubMed
7. Sharma AM, Kline B. The United States registry for fibromuscular dysplasia: new findings and breaking myths. Tech Vasc Interv Radiol 2014;17:258-63.DOIPubMed
8. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982;13:46-52.DOI
9. Divjak I, Slankamenac P, Jovicevic M, Zikic TR, Jesic A. [Diagnosis and outcome of cervical artery dissection]. Med Pregl 2011;64:392-6.DOIPubMed
10. Bejot Y, Aboa-Eboule C, Debette S, Pezzini A, Tatlisumak T, Engelter S, Grond-Ginsbach C, Touze E, Sessa M, Metso T, Metso A, Kloss M, Caso V, Dallongeville J, Lyrer P, Leys D, Giroud M, Pandolfo M, Abboud S, CADISP Group. Characteristics and outcomes of patients with multiple cervical artery dissection. Stroke 2014;45:37-41.DOIPubMed
11. Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, Gray WA, Gupta R, Hamburg NM, Katzen BT, Lookstein RA, Lumsden AB, Newburger JW, Rundek T, Sperati CJ, Stanley JC; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiopulmonary; Critical Care, Perioperative and Resuscitation; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Radiology and Intervention; American Heart Association Council on Epidemiology and Prevention, American Heart Association Council on Functional Genomics and Translational Biology; American Heart Association Council for High Blood Pressure Research; American Heart Association Council on the Kidney in Cardiovascular Disease; American Heart Association Stroke Council. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014;129:1048-78.DOIPubMed
12. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-236.DOIPubMed
Natarajan Aravindan et al., Cancer Drug Resistance, 2019
Claudia Tulotta et al., Journal of Cancer Metastasis and Treatment, 2019
Thibault Gauduchon et al., Journal of Cancer Metastasis and Treatment, 2019
Natarajan Aravindan et al., Cancer Drug Resistance, 2019
Leonardo G. da Fonseca et al., Hepatoma Research, 2019
Lauren K. Meyer et al., Cancer Drug Resistance, 2019
Janice Miller et al., Journal of Cancer Metastasis and Treatment, 2019
Jesus Rodriguez-Pascual et al., Cancer Drug Resistance, 2019
Andrea Bild et al., Cancer Drug Resistance, 2019
Filippo Merloni et al., Cancer Drug Resistance, 2019